Log in

NYSE:LH - Laboratory Corp. of America Stock Price, Forecast & News

$171.68
+0.71 (+0.42 %)
(As of 12/6/2019 04:00 PM ET)
Today's Range
$171.56
Now: $171.68
$173.13
50-Day Range
$162.55
MA: $168.83
$174.11
52-Week Range
$119.38
Now: $171.68
$178.44
Volume532,704 shs
Average Volume710,184 shs
Market Capitalization$16.67 billion
P/E Ratio15.58
Dividend YieldN/A
Beta1.03
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development. It offers various clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually-transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. Read More…

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryHealth Care Services
SectorMedical
CUSIP50540R40
Phone336-229-1127

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.33 billion
Cash Flow$16.62 per share
Book Value$69.09 per share

Profitability

Net Income$883.70 million

Miscellaneous

Employees61,000
Market Cap$16.67 billion
Next Earnings Date2/6/2020 (Estimated)
OptionableOptionable

Receive LH News and Ratings via Email

Sign-up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter.


Laboratory Corp. of America (NYSE:LH) Frequently Asked Questions

What is Laboratory Corp. of America's stock symbol?

Laboratory Corp. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

How were Laboratory Corp. of America's earnings last quarter?

Laboratory Corp. of America Holdings (NYSE:LH) released its quarterly earnings data on Thursday, October, 24th. The medical research company reported $2.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.85 by $0.05. The medical research company earned $2.93 billion during the quarter, compared to analyst estimates of $2.91 billion. Laboratory Corp. of America had a net margin of 6.63% and a return on equity of 15.33%. The business's quarterly revenue was up 3.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.74 earnings per share. View Laboratory Corp. of America's Earnings History.

When is Laboratory Corp. of America's next earnings date?

Laboratory Corp. of America is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for Laboratory Corp. of America.

What guidance has Laboratory Corp. of America issued on next quarter's earnings?

Laboratory Corp. of America updated its FY19 earnings guidance on Thursday, October, 24th. The company provided EPS guidance of $11.20-$11.30 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $11.27. The company issued revenue guidance of $11.5-$11.56 billion, compared to the consensus revenue estimate of $11.48 billion.

What price target have analysts set for LH?

12 analysts have issued twelve-month target prices for Laboratory Corp. of America's stock. Their forecasts range from $164.00 to $220.00. On average, they expect Laboratory Corp. of America's share price to reach $186.80 in the next twelve months. This suggests a possible upside of 8.8% from the stock's current price. View Analyst Price Targets for Laboratory Corp. of America.

What is the consensus analysts' recommendation for Laboratory Corp. of America?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Laboratory Corp. of America in the last year. There are currently 1 sell rating, 4 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Laboratory Corp. of America.

Has Laboratory Corp. of America been receiving favorable news coverage?

News headlines about LH stock have trended extremely negative on Saturday, InfoTrie reports. InfoTrie rates the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Laboratory Corp. of America earned a media sentiment score of -4.2 on InfoTrie's scale. They also gave media stories about the medical research company a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an effect on the stock's share price in the next few days. View News Stories for Laboratory Corp. of America.

Are investors shorting Laboratory Corp. of America?

Laboratory Corp. of America saw a increase in short interest in the month of October. As of October 31st, there was short interest totalling 1,970,000 shares, an increase of 13.9% from the September 30th total of 1,730,000 shares. Based on an average daily trading volume, of 533,400 shares, the days-to-cover ratio is presently 3.7 days. Currently, 2.0% of the shares of the company are sold short. View Laboratory Corp. of America's Current Options Chain.

Who are some of Laboratory Corp. of America's key competitors?

What other stocks do shareholders of Laboratory Corp. of America own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Laboratory Corp. of America investors own include CA (CA), BlackRock (BLK), Micron Technology (MU), Amgen (AMGN), Endologix (ELGX), NVIDIA (NVDA), Allergan (AGN), Intel (INTC), Chipotle Mexican Grill (CMG) and Cisco Systems (CSCO).

Who are Laboratory Corp. of America's key executives?

Laboratory Corp. of America's management team includes the folowing people:
  • Mr. David P. King, Chairman, CEO & Pres (Age 63)
  • Mr. Glenn A. Eisenberg, CFO & Exec. VP (Age 58)
  • Mr. F. Samuel Eberts III, Chief Legal Officer, Chief Compliance Officer, Sr. VP & Sec. (Age 59)
  • Mr. John D. Ratliff, Chief Exec. Officer of Covance Drug Devel. (Age 59)
  • Dr. Michelle Abelson, Laboratory Director of Operations

Who are Laboratory Corp. of America's major shareholders?

Laboratory Corp. of America's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include State Street Corp (4.44%), Boston Partners (1.70%), California Public Employees Retirement System (0.82%), Sumitomo Mitsui Trust Holdings Inc. (0.55%), Calamos Advisors LLC (0.55%) and Veritas Investment Management LLP (0.53%). Company insiders that own Laboratory Corp. of America stock include Adam H Schechter, David P King, Der Vaart Sandra D Van, Edward T Dodson, Glenn A Eisenberg, Kerrii B Anderson, Lance Berberian, Lisa J Uthgenannt, M Huff Gary, R Sanders Williams and Robert E Mittelstaedt Jr. View Institutional Ownership Trends for Laboratory Corp. of America.

Which major investors are selling Laboratory Corp. of America stock?

LH stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, Point72 Asset Management L.P., State of New Jersey Common Pension Fund D, Global Thematic Partners LLC, Banco Santander S.A., Man Group plc, First Trust Advisors LP and Assenagon Asset Management S.A.. Company insiders that have sold Laboratory Corp. of America company stock in the last year include David P King, Der Vaart Sandra D Van, Glenn A Eisenberg, Kerrii B Anderson, Lance Berberian, Lisa J Uthgenannt, R Sanders Williams and Robert E Mittelstaedt Jr. View Insider Buying and Selling for Laboratory Corp. of America.

Which major investors are buying Laboratory Corp. of America stock?

LH stock was bought by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, California Public Employees Retirement System, Teacher Retirement System of Texas, Zurcher Kantonalbank Zurich Cantonalbank, Sumitomo Mitsui Trust Holdings Inc., State of Alaska Department of Revenue, Squarepoint Ops LLC and Great Lakes Advisors LLC. View Insider Buying and Selling for Laboratory Corp. of America.

How do I buy shares of Laboratory Corp. of America?

Shares of LH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Laboratory Corp. of America's stock price today?

One share of LH stock can currently be purchased for approximately $171.68.

How big of a company is Laboratory Corp. of America?

Laboratory Corp. of America has a market capitalization of $16.67 billion and generates $11.33 billion in revenue each year. The medical research company earns $883.70 million in net income (profit) each year or $11.02 on an earnings per share basis. Laboratory Corp. of America employs 61,000 workers across the globe.View Additional Information About Laboratory Corp. of America.

What is Laboratory Corp. of America's official website?

The official website for Laboratory Corp. of America is http://www.labcorp.com/.

How can I contact Laboratory Corp. of America?

Laboratory Corp. of America's mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company can be reached via phone at 336-229-1127 or via email at [email protected]


MarketBeat Community Rating for Laboratory Corp. of America (NYSE LH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  481 (Vote Outperform)
Underperform Votes:  520 (Vote Underperform)
Total Votes:  1,001
MarketBeat's community ratings are surveys of what our community members think about Laboratory Corp. of America and other stocks. Vote "Outperform" if you believe LH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/7/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel